Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: Implications for the use of antenatal steroids

Developmental Brain Research

Volumn 111, Issue 1, 1998, Pages 11-24

  Slotkin, T A ^a   Zhang, J ^a   McCook, E C ^a   Seidler, F J ^a  

^a Dept of Pharmacol and Cancer B ^*  (United States)

Author keywords

AP I binding protein; c fos; Dexamethasone; Prematurity

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; GLUCOCORTICOID; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; GENE INDUCTION; GENE REPRESSION; LIVER; NEUROTOXICITY; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; CELL NUCLEUS; DEXAMETHASONE; EMBRYO; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; LIVER; PREGNANCY; PRENATAL CARE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0032212101     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00115-1     Document Type: Article

References (79)

1. Anderson G.G., Lamden M., Cidlowski J.A., Ashikaga T. Comparative pulmonary surfactant-inducing effect of three corticosteroids in the near-term rat. Am. J. Obstet. Gynecol. 139:1981;562-564.
2. Barlow S.M., Knight A.F., Sullivan F.M. Diazepam-induced cleft palate in the mouse: the role of endogenous maternal corticosterone. Teratology. 21:1980;149-155.
3. M.C. Bohn, Glucocorticoid induced teratologies of the nervous system, in: J. Yanai (Ed.), Neurobehavioral Teratology, Elsevier, Amsterdam, 1984, pp. 365-387.
4. Briski K.P., DiPasquale B.M., Gillen E. Induction of immediate-early gene expression in preoptic and hypothalamic neurons by the glucocorticoid receptor agonist, dexamethasone. Brain Res. 768:1997;185-196.
5. Carlos R.Q., Seidler F.J., Lappi S.E., Slotkin T.A. Fetal dexamethasone exposure affects basal ornithine decarboxylase activity in developing rat brain regions and alters acute responses to hypoxia and maternal separation. Biol. Neonate. 59:1991;69-77.
6. Carlos R.Q., Seidler F.J., Slotkin T.A. Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: a critical period for regionally selective alterations? Teratology. 46:1992;45-59.
7. Carroll B.J., Heath B., Jarrett D.B. Corticosteroids in brain tissue. Endocrinology. 97:1975;290-300.
8. Chirgwin S.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of RNA from living tissues using a modified guanidine thiocyanate/cesium chloride method. Biochemistry. 18:1979;5294-5299.
9. Chiu R., Boyle W.J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 54:1988;541-552.
10. Collaço-Moraes Y., De Belleroche J.S. Differential effects of dexamethasone on the induction of c-fos, zif-268 and ornithine decarboxylase by excitotoxin. Biochem. Soc. Trans. 22:1994;S151.
11. Crocker J.F.S., Ogborn M.R. Glucocorticoid teratogenesis in the developing nephron. Teratology. 43:1991;571-574.
12. Curran T. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene. 2:1987;74-87.
13. Curran T., Morgan J.I. Fos: an immediate-early transcription factor in neurons. J. Neurobiol. 26:1995;403-412.
14. De Kloet E.R. Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol. 12:1991;95-164.
15. Dieringer C., Lamartiniere C., Schiller C., Lucier G. Altered ontogeny of hepatic steroid-metabolizing enzymes by pure polychlorinated biphenyl congeners. Biochem. Pharmacol. 28:1979;2511-2517.
16. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R., Gluckman P. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. Mol. Brain Res. 25:1994;19-33.
17. Gatherer D. Gene knockouts and murine development. Dev. Growth Differ. 35:1993;365-370.
18. Gilstrap L.C., Christensen R., Clewell W.H., D'Alton M.E., Davidson E.C., Escobedo M.B., Gjerdingen D.K., Goddard-Finegold J., Goldenberg R.L., Grimes D.A., Hansen T.N., Kauffman R.E., Keeler E.B., Oh W., Susman E.J., Vogel M.G., Avery M.E., Ballard R.A., Crowley P., Garite T., Hankins G.D.V., Jobe A.H., Koppe J.G., Maher J.E., Merkatz I.R., Shankaran S., Simpson K.N., Sinclair J.C., Slotkin T.A., Taeusch H.W., Wright L.L. Effect of corticosteroids for fetal maturation on perinatal outcomes. J. Am. Med. Assoc. 273:1994;413-418.
19. Hesketh J.E., Whitelaw P.F. The role of cellular oncogenes in myogenesis and muscle cell hypertrophy. Int. J. Biochem. 24:1992;193-203.
20. Holson R.R., Gough B., Sullivan P., Badger T., Sheehan D.M. Prenatal dexamethasone or stress, but not ACTH or corticosterone, alter sexual behavior in male rats. Neurotoxicol. Teratol. 17:1995;393-401.
21. Huff R.A., Seidler F.J., Slotkin T.A. Glucocorticoids regulate the ontogenetic transition of adrenergic receptor subtypes in rat liver. Life Sci. 48:1991;1059-1066.
22. Iida H., Kast A., Tsunenari Y., Asakura M. Corticosterone induction of cleft palate in mice dosed with orciprenaline sulfate. Teratology. 38:1988;15-27.
23. Jesberger J.A., Richardson J.S. Animal models of depression: parallels and correlates to severe depression in humans. Biol. Psychiatry. 20:1985;764-784.
24. β subunits in neonatal liver. Mol. Cell. Endocrinol. 99:1994;95-102.
25. Johnson T.A., Li J., Beer D.G. Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells. Mol. Carcinog. 17:1996;70-77.
26. Kasik J.W., Wan Y.-J.Y., Ozato K. A burst of c-fos gene expression in the mouse occurs at birth. Mol. Cell. Biol. 7:1987;3349-3352.
27. Kawai Y., Arinze I.J. Glucocorticoid regulation of G-protein subunits in neonatal liver. Mol. Cell. Endocrinol. 90:1993;203-209.
28. Kay E.D., Goldman A.S., Caniel J.C. Common biochemical pathway of dysmorphogenesis in murine embryos: use of the glucocorticoid pathway by phenytoin. Teratog. Carcinog. Mutag. 10:1990;31-39.
29. Kerppola T.K., Luk D., Curran T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13:1993;3782-3791.
30. Kudlacz E.M., Navarro H.A., Slotkin T.A. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. J. Pharmacol. Exp. Ther. 250:1989;236-240.
31. Lamers W.H., Mooren P.G. Multihormonal control of enzyme clusters in rat liver ontogenesis: II. Role of glucocorticosteroid and thyroid hormone and of glucagon and insulin. Mech. Aging Dev. 15:1981;93-118.
32. Levitt N.S., Lindsay R.S., Holmes M.C., Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology. 64:1996;412-418.
33. Matiuck N.V., Swain J.L. Proto-oncogenes and cardiac development. Trends Cardiovasc. Med. 2:1992;61-65.
34. Meyer J.S. Biochemical effects of corticosteroids on neural tissues. Physiol. Rev. 65:1985;946-1020.
35. Miao G.G., Curran T. Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle. Mol. Cell. Biol. 14:1994;4295-4310.
36. Moriguchi M., Scott W.J. Prevention of caffeine-induced limb malformations by maternal adrenalectomy. Teratology. 33:1986;319-322.
37. Morris G., Slotkin T.A. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat. J. Pharmacol. Exp. Ther. 233:1985;141-147.
38. Navarro H.A., Kudlacz E.M., Eylers J.P., Slotkin T.A. Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung. Teratology. 40:1989;433-438.
39. Navarro H.A., Kudlacz E.M., Slotkin T.A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate. 60:1991;127-136.
40. Navarro H.A., Lachowicz J., Bartolome J., Whitmore W.L., Slotkin T.A. Effects of prenatal dexamethasone on development of ornithine decarboxylase activity in brain and peripheral tissues of rats. Pediatr. Res. 24:1988;465-469.
41. Pennypacker K. Transcription factors in brain injury. Histol. Histopathol. 12:1997;1125-1133.
42. Pennypacker K.R., Dreyer D., Hong J.S., McMillian M.K. Elevated basal AP-1 DNA binding activity in developing rat brain. Mol. Brain Res. 19:1993;349-352.
43. Pennypacker K.R., Hong J.S., Douglass J., McMillian M.K. Constitutive expression of AP-1 transcription factors in the rat adrenal: effects of nicotine. J. Biol. Chem. 267:1992;20148-20152.
44. Pennypacker K.R., Hong J.S., McMillian M.K. Pharmacological regulation of AP-1 transcription factor DNA binding activity. FASEB J. 8:1994;475-478.
45. Pennypacker K.R., Hong J.S., McMillian M.K. Implications of prolonged expression of Fos-related antigens. Trends Pharmacol. Sci. 16:1995;317-321.
46. Pennypacker K.R., Hudson P.M., Hong J.S., McMillian M.K. DNA binding activity of CREB transcription factors during ontogeny of the central nervous system. Dev. Brain Res. 86:1995;242-249.
47. Preston G.A., Lyon T.T., Yin Y.X., Lang J.E., Solomon G., Annab L., Srinivasan D.G., Alcorta D.A., Barrett J.C. Induction of apoptosis by c-Fos protein. Mol. Cell. Biol. 16:1996;211-218.
48. Shelly L.L., Yeoh G.C.T. Effects of dexamethasone and cAMP on tyrosine aminotransferase expression in cultured fetal rat hepatocytes. Eur. J. Biochem. 199:1991;475-481.
49. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse? J. Pharmacol. Exp. Ther. 285:1998;931-945.
50. Slotkin T.A., Baker F.E., Dobbins S.S., Eylers J.P., Lappi S.E., Seidler F.J. Prenatal terbutaline exposure in the rat: selective effects on development of noradrenergic projections to cerebellum. Brain Res. Bull. 23:1989;263-265.
51. Slotkin T.A., Barnes G., Lau C., Seidler F.J., Trepanier P., Weigel S.J., Whitmore W.L. Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. J. Pharmacol. Exp. Ther. 221:1982;686-693.
52. Slotkin T.A., Barnes G.A., McCook E.C., Seidler F.J. Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Dev. Brain Res. 93:1996;155-161.
53. Slotkin T.A., Lappi S.E., McCook E.C., Tayyeb M.I., Eylers J.P., Seidler F.J. Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol. Neonate. 61:1992;326-336.
54. Slotkin T.A., Lappi S.E., Seidler F.J. β-Adrenergic control of c-fos expression in fetal and neonatal rat tissues: relationship to cell differentiation and teratogenesis. Toxicol. Appl. Pharmacol. 133:1995;188-195.
55. 3H] desmethylimipramine binding sites after fetal exposure to dexamethasone Res. Comm. Chem. Pathol. Pharmacol. 73:1991;3-19.
56. Slotkin T.A., Lau C., Lappi S.E., Seidler F.J. Can intracellular signaling pathways predict developmental abnormalities? Sensitivity of the adenylyl cyclase/c-fos protooncogene cascade to β-adrenergic agonists and glucocorticoids in fetal rat. Biomarkers. 1:1996;115-122.
57. Slotkin T.A., Lau C., McCook E.C., Lappi S.E., Seidler F.J. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization? Toxicol. Appl. Pharmacol. 127:1994;64-75.
58. Slotkin T.A., McCook E.C., Seidler F.J. Glucocorticoids regulate the development of intracellular signaling: enhanced forebrain adenylate cyclase catalytic subunit activity after fetal dexamethasone exposure. Brain Res. Bull. 32:1993;359-364.
59. Slotkin T.A., McCook E.C., Seidler F.J. Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res. 750:1997;180-188.
60. Slotkin T.A., Seidler F.J. Transient postnatal elevation of norepinephrine content and turnover in brain regions of rats exposed to terbutaline prenatally: evidence for autoregulation of noradrenergic development? Res. Comm. Chem. Pathol. Pharmacol. 76:1992;269-278.
61. Slotkin T.A., Seidler F.J., Kavlock R.J., Bartolome J.V. Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues. Teratology. 43:1991;301-306.
62. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.G., Schilling K., Robertson L.M., Curran T., Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
63. Smith M., Burke Z., Carter D. Tonic suppression of adrenal AP-1 activity by glucocorticoids. Mol. Cell. Endocrinol. 122:1996;151-158.
64. Smith M.A., Kim S.Y., Vanoers H.J.J., Levine S. Maternal deprivation and stress induce immediate-early genes in the infant rat brain. Endocrinology. 138:1997;4622-4628.
65. G.W. Snedecor, W.G. Cochran, Statistical Methods, Iowa State Univ. Press, Ames, IA, 1967.
66. Sonnenberg J.L., MacGregor-Leon P.F., Curran T., Morgan J.I. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron. 3:1989;359-365.
67. Tsuneishi S., Takada S., Motoike T., Ohashi T., Sano K., Nakamura H. Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain. Dev. Brain Res. 61:1991;117-123.
68. Unlap T., Jope R.S. Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Mol. Brain Res. 24:1994;275-282.
69. Vendrell M., Zawia N.H., Serratosa J., Bondy S.C. c-fos and ornithine decarboxylase gene expression in brain as early markers of neurotoxicity. Brain Res. 544:1991;291-296.
70. Wagner J.P., Seidler F.J., Lappi S.E., McCook E.C., Slotkin T.A. Role of thyroid status in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase, ornithine decarboxylase and c-fos protooncogene expression. J. Pharmacol. Exp. Ther. 271:1994;472-483.
71. Wagner J.P., Seidler F.J., Lappi S.E., McCook E.C., Slotkin T.A. Role of presynaptic input in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase, and c-fos protooncogene expression. J. Pharmacol. Exp. Ther. 273:1995;415-426.
72. Wagner J.P., Seidler F.J., Schachat F.H., Slotkin T.A. Beta adrenergic control of c-fos protooncogene expression in developing rat brain regions. J. Pharmacol. Exp. Ther. 269:1994;1292-1299.
73. Wan W., Wetmore L., Sorensen C.M., Greenberg A.H., Nance D.M. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res. Bull. 34:1994;7-14.
74. Wrighton C., Busslinger M. Direct transcriptional stimulation of the ornithine decarboxylase gene by Fos in PC12 cells, but not in fibroblasts. Mol. Cell. Biol. 13:1993;4657-4669.
75. Xiao Y., Xu R., Sokolowski B.H.A., Harry G.J., Gordon M.N., Pennypacker K. Neurons adapt to neurotoxin insults by alter AP-1 binding activities in rat brain. Soc. Neurosci. Abstr. 23:1997;2203.
76. Yamada G., Sugimura K., Stuart E.T. Gene-targeting approaches in the study of cellular processes involved in growth or differentiation: advances in the analysis of oncogenes, tumour-suppressor genes, cytokine/receptor systems and developmental control genes. Eur. J. Biochem. 226:1994;739-749.
77. Zahalka E.A., Seidler F.J., Slotkin T.A. Dexamethasone treatment in utero enhances neonatal cholinergic nerve terminal development in rat brain. Res. Comm. Chem. Pathol. Pharmacol. 81:1993;191-198.
78. Zawia N.H., Bondy S.C. Electrically stimulated rapid gene expression in the brain: ornithine decarboxylase and c-fos. Mol. Brain Res. 7:1990;243-247.
79. Zawia N.H., Harry G.J. Trimethyltin-induced c-fos expression: adolescent vs. neonatal rat hippocampus. Toxicol. Appl. Pharmacol. 121:1993;99-102.